Literature DB >> 15842596

Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review.

Magda Guilera1, Agustín Balboa, Fermín Mearin.   

Abstract

UNLABELLED: Irritable bowel syndrome (IBS) is a heterogeneous condition characterized by the presence of abdominal discomfort or pain and bowel habit alterations: constipation (C-IBS), diarrhea (D-IBS), or alternating C and D (A-IBS). Its clinical course is poorly known.
OBJECTIVES: (i) To compare bowel habit subtypes distribution in IBS according to sample origin and diagnosis criteria; (ii) To evaluate IBS temporal patterns based on follow-up studies.
METHODS: A literature search (1966-2003) was conducted in the MEDLINE and EMBASE databases. A total of 72 studies were found and 22 were finally selected.
RESULTS: Population-based studies from the United States (Manning) found similar distribution among C-IBS, D-IBS, and A-IBS, while European studies (Rome I, Rome II, or self-reporting) showed either C-IBS or A-IBS as the most prevalent subtypes. Primary care office-based studies (Rome I or Rome II) showed A-IBS as the most prevalent group. Gastroenterology specialized office-based studies found either C-IBS or D-IBS as the most frequently reported subtype. Prospective follow-up investigations showed that the most frequent IBS temporal pattern profile consists of mild to moderate symptoms appearing in cluster in an intermittent way, about once a week, and lasting 2-5 days on average.
CONCLUSION: IBS clinical subtypes distribution differs depending on the population evaluated, the geographical location, and the criteria employed to define IBS and bowel habit subtypes. In most cases, clinical course is characterized by the presence of mild-to-moderate symptoms appearing sequentially. Prospective studies, using clear and stable diagnostic criteria and subtype definitions, and based on daily data collection should further characterize IBS clinical course.

Entities:  

Mesh:

Year:  2005        PMID: 15842596     DOI: 10.1111/j.1572-0241.2005.40674.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  34 in total

1.  The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial.

Authors:  William D Chey; Borko Nojkov; Joel H Rubenstein; Richard R Dobhan; Joel K Greenson; Brooks D Cash
Journal:  Am J Gastroenterol       Date:  2010-02-23       Impact factor: 10.864

Review 2.  American Gastroenterological Association technical review on constipation.

Authors:  Adil E Bharucha; John H Pemberton; G Richard Locke
Journal:  Gastroenterology       Date:  2013-01       Impact factor: 22.682

Review 3.  Irritable bowel syndrome.

Authors:  N J Talley
Journal:  Intern Med J       Date:  2006-11       Impact factor: 2.048

4.  Novel Therapies in IBS-D Treatment.

Authors:  Judy Nee; Mohammed Zakari; Anthony J Lembo
Journal:  Curr Treat Options Gastroenterol       Date:  2015-12

5.  Irritable Bowel Syndrome: Pain in Spain.

Authors:  Fermín Mearin
Journal:  Am J Gastroenterol       Date:  2017-11-14       Impact factor: 10.864

6.  Subtypes of irritable bowel syndrome in children and adolescents.

Authors:  Mariella M Self; Danita I Czyzewski; Bruno P Chumpitazi; Erica M Weidler; Robert J Shulman
Journal:  Clin Gastroenterol Hepatol       Date:  2014-01-29       Impact factor: 11.382

Review 7.  Chronic Constipation.

Authors:  Adil E Bharucha; Arnold Wald
Journal:  Mayo Clin Proc       Date:  2019-05-01       Impact factor: 7.616

8.  The current prevalence of irritable bowel syndrome in Asia.

Authors:  Full-Young Chang; Ching-Liang Lu; Tseng-Shing Chen
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

9.  Insights into normal and disordered bowel habits from bowel diaries.

Authors:  Adil E Bharucha; Barbara M Seide; Alan R Zinsmeister; L Joseph Melton
Journal:  Am J Gastroenterol       Date:  2007-11-16       Impact factor: 10.864

10.  No association of G-protein beta polypeptide 3 polymorphism with irritable bowel syndrome: evidence from a meta-analysis.

Authors:  Zhi-Gang Pan; Chen Xiao; Dong-Xing Su
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.